HomeVTRLY • OTCMKTS
add
Vitrolife ADR
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 959.00M | 5.97% |
Operating expense | 361.00M | 19.54% |
Net income | 139.00M | 103.33% |
Net profit margin | 14.49 | 103.14% |
Earnings per share | 1.02 | 14.61% |
EBITDA | 337.00M | 26.69% |
Effective tax rate | 23.63% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.14B | 31.82% |
Total assets | 17.45B | 6.84% |
Total liabilities | 3.80B | 5.52% |
Total equity | 13.64B | — |
Shares outstanding | 135.42M | — |
Price to book | 0.18 | — |
Return on assets | 3.28% | — |
Return on capital | 3.64% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 139.00M | 103.33% |
Cash from operations | 268.00M | 56.73% |
Cash from investing | -75.00M | -127.27% |
Cash from financing | -13.00M | -750.00% |
Net change in cash | 210.00M | 153.01% |
Free cash flow | 101.12M | -40.56% |
About
Founded
1989
Website
Employees
1,120
